This study introduces a dual-release transdermal drug delivery system using a hydrogel matrix of cross-linked gelatin and sodium carboxymethyl cellulose (NaCMC). Designed for immediate drug release from microneedles (MNs) and sustained release from microcapsules (MCs), this system utilizes lidocaine hydrochloride as the model drug. The fabrication process involved casting the hydrogel into MN molds, with MCs embedded in the backing layer, establishing a dual-release mechanism. MCs of gelatin and NaCMC were prepared by emulsion-crosslinking method and using glutaraldehyde as a crosslinker. MCs ranged in size from 50 to 264 μm and exhibited the highest drug release in acidic environments, showcasing a pH-responsive nature. Drug loading efficiency reached 9.8 %, while encapsulation efficiency was 75.8 %. The MNs, which had a conical shape and strong mechanical properties, demonstrated excellent penetration capabilities. The in vitro release profile indicated an initial burst within 10 min, followed by sustained release over 240 min, in line with the Korsmeyer-Peppas model. Additionally, the system displayed significant antimicrobial properties and good biocompatibility, with cell viability exceeding 86 %. This confirms its potential as a safe and effective platform for transdermal drug delivery.
Read full abstract